Eric L Nuermberger Selected Research

Eric L Nuermberger Research Topics

Disease

64	Tuberculosis (Tuberculoses) 04/2024 - 02/2004
30	Infections 12/2022 - 08/2009
14	Buruli Ulcer 10/2021 - 07/2010
12	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 04/2024 - 08/2009
6	Granuloma 06/2015 - 09/2004
5	Latent Tuberculosis 04/2023 - 12/2009
5	Pulmonary Tuberculosis 01/2022 - 08/2009
4	Body Weight (Weight, Body) 01/2019 - 07/2012
3	Hypoxia (Hypoxemia) 01/2020 - 03/2009
2	Extensively Drug-Resistant Tuberculosis 02/2024 - 11/2021
2	Persistent Infection 10/2023 - 01/2021
2	Acquired Immunodeficiency Syndrome (AIDS) 12/2021 - 06/2020
2	Ulcer 01/2019 - 01/2013
1	Bacteremia 10/2022
1	Wound Infection (Wound Infections) 10/2022
1	Staphylococcal Infections 10/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Bacterial Infections (Bacterial Infection) 12/2020
1	Lung Diseases (Lung Disease) 01/2019
1	Nontuberculous Mycobacterium Infections 01/2019
1	Necrosis 06/2015
1	Hearing Loss (Hearing Impairment) 01/2015
1	Neglected Diseases 01/2014
1	Skin Diseases (Skin Disease) 10/2011
1	Cicatrix (Scar) 03/2011
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 07/2010

Drug/Important Bio-Agent (IBA)

23	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 02/2004
21	Isoniazid (Ftivazide)FDA LinkGeneric 04/2024 - 02/2004
20	Pyrazinamide FDA LinkGeneric 01/2022 - 02/2004
17	rifapentine (Priftin)FDA Link 04/2023 - 12/2005
14	pretomanidIBA 02/2024 - 01/2011
14	bedaquiline (R207910)IBA 02/2024 - 09/2011
14	Moxifloxacin (Avelox)FDA Link 01/2022 - 02/2004
13	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 04/2011
13	AerosolsIBA 01/2019 - 03/2009
10	Linezolid (Zyvox)FDA Link 02/2024 - 08/2009
10	RifamycinsIBA 01/2022 - 07/2006
6	FluoroquinolonesIBA 01/2022 - 04/2011
5	Oxazolidinones (2 Oxazolidone)IBA 01/2023 - 08/2009
5	Streptomycin (Streptomycin Sulfate)FDA Link 01/2019 - 10/2010
5	Clofazimine (Lamprene)FDA Link 01/2019 - 05/2013
4	DiarylquinolinesIBA 01/2023 - 01/2021
4	VaccinesIBA 01/2020 - 09/2011
4	Ethambutol (Myambutol)FDA LinkGeneric 07/2015 - 08/2012
3	Oxidoreductases (Dehydrogenase)IBA 10/2023 - 01/2019
3	Antitubercular AgentsIBA 10/2023 - 01/2020
3	Rifabutin (Ansamycin)FDA Link 04/2023 - 01/2022
3	LactamsIBA 01/2022 - 01/2019
3	Drug CombinationsIBA 01/2022 - 04/2011
3	telacebecIBA 10/2021 - 01/2019
3	NitroimidazolesIBA 01/2020 - 01/2011
2	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 04/2023 - 01/2023
2	TBAJ-876IBA 01/2023 - 11/2021
2	OPC-67683IBA 01/2022 - 01/2020
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2022 - 01/2021
2	Meropenem (Merrem)FDA LinkGeneric 01/2022 - 01/2022
2	Imipenem FDA Link 11/2021 - 01/2019
2	ProdrugsIBA 01/2020 - 03/2015
2	mycolactoneIBA 01/2019 - 01/2013
2	AcidsIBA 01/2014 - 10/2012
2	Biomarkers (Surrogate Marker)IBA 01/2012 - 01/2011
1	contezolidIBA 12/2023
1	duroquinol oxidaseIBA 10/2023
1	CytochromesIBA 10/2023
1	PlacebosIBA 10/2022
1	Lysine-tRNA LigaseIBA 10/2022
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2022
1	AcetyltransferasesIBA 12/2021
1	Vitamin K 2 (Vitamin K2)IBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	meropenem and vaborbactamIBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	MacrolidesIBA 01/2019
1	Tigecycline (Tygacil)FDA Link 01/2019
1	relebactamIBA 01/2019
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2016
1	Oxygen (Dioxygen)IBA 03/2015
1	VXc-486IBA 03/2015
1	TBA-354IBA 01/2015
1	Levofloxacin (Levaquin)FDA Link 07/2013
1	beta-LactamsIBA 05/2013
1	trichostatin A (A 300)IBA 11/2012
1	NitrogenIBA 10/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2012
1	CarbonIBA 10/2012
1	pimonidazoleIBA 02/2012
1	7- (7- amino- 7- methyl- 5- azaspiro(2.4)heptan- 5- yl)- 6- fluoro- 1- (2- fluoro- 1- cyclopropyl)- 1,4- dihydro- 8- methoxy- 4- oxo- 3- quinolinecarboxylic acidIBA 04/2011
1	CytokinesIBA 03/2011
1	Glucose (Dextrose)FDA LinkGeneric 11/2009
1	PNU-100480IBA 08/2009

Therapy/Procedure

10	Duration of Therapy 01/2022 - 02/2004
9	Therapeutics 04/2023 - 11/2002
7	Drug Therapy (Chemotherapy) 01/2017 - 02/2004
3	Skin Transplantation (Skin Grafting) 01/2022 - 10/2011
2	Aftercare (After-Treatment) 01/2016 - 01/2013
2	Intramuscular Injections 01/2015 - 10/2010
1	Salvage Therapy 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 07/2010